| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8243521 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 7 Pages |
Abstract
Conclusions: Celecoxib in combination with definitive CRT is associated with acceptable acute toxicity, but higher than expected late complications. Celecoxib is associated with a modest reduction in the angiogenic biomarker IFP, but this does not correspond with tumor response.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Fernanda G. M.D., Philip M.B.B.S., F.R.A.N.Z.C.R., Corinne M.D., F.R.C.P.C., Michael M.D., F.R.C.P.C., Amit M.B., F.R.C.P.C., Amy Syed, Melania M.Sc., Wilfred M.B., F.R.C.P.C., Lee M.D., M.H.P.E., Anthony M.D., F.R.C.P.C.,